 |
CDER Sponsored Workshops and
Meetings
Drug Information Association (DIA): Cardiovascular Safety, QT, and Arrhythmia Assessment in Drug Development, April 29-May 1, 2009, Hyatt Regency Besthesda, Bethesda, MD. Meeting information
Public Workshop on Developing a Consolidated Pediatric Rheumatology Observational Registry, May 12-13, 2009. Meeting Information
Applied Biopharmaceutics and Quality by Design for Dissolution/Release Specification Setting:
Product Quality for Patient Benefit, June 10-12, 2009, Hilton Washington DC/Rockville
1750 Rockville Pike, Rockville, MD. Meeting Information
2009 PDA/FDA Asia-Pacific Pharmaceutical Ingredient Supply Chain Conference, June 15-19, 2009, Shanghai, China. Meeting Information and registration
2009 PDA/FDA Joint Regulatory Conference, September 14-18, 2009, Renaissance Hotel, 999 9th Street NW, Washington, D.C. Meeting Information and registration
Quality Risk Management – Implementation Strategies; US FDA/CDER and University of Rhode Island College of Pharmacy Conference, June 15-16, 2009, Hyatt Regency Bethesda, Bethesda, Maryland. Meeting Information.
Past
FDA Small Pharmaceutical Business Assistance Educational Forum Public Workshop, April 23, 2009. Meeting Information and registration
Propylthiouracyl (PTU)-Related Liver Toxicity; Public Workshop April 18, 2009, Washington, D.C. Meeting Information
Designating Additions to the Current List of Tropical Diseases in the Food and Drug Administration Amendments Act; Public Hearing, December 12, 2008, National Transportation Safety Board Boardroom and Conference Center, 429 L'Enfant Plaza, SW., Washington, DC 20594. Meeting information
PDA/FDA Pharmaceutical Ingredient Supply Chain Conference,
December 3 - 5, 2008, Coronado, California Meeting information and registration
International Conference on Harmonization (ICH) Public Meeting,
October 21, 2008, Rockville, Maryland Meeting information and registration
Public Hearing for Over-the-Counter Cough and Cold Medications,
October 2, 2008, Beltsville, Maryland Meeting informatiosn and registration
Pubic Workshop: Developing Guidance on Conducting Scientifically Sound Pharmacoepidemiologic Safety Studies Using Large Electronic Healthcare Data Sets, Wednesday, May 7, 2008, Silver Spring, MD. Federal Register Notice
Meeting for Public Comment on the Pilot Program to Evaluate Proposed Name Submissions, June 5 and 6, 2008, Silver Spring, MD. Meeting information
FDA Small Pharmaceutical Business Assistance Educational Forum Public Workshop, April 29, 2008, Dallas Texas. Meeting Information
International Conference on Harmonization (ICH) Preparation for ICH meetings in Portland, Oregon, Rockville, MD, April 4, 2008. Meeting Information
Clinical Trial Design for Community-Acquired Pneumonia; Public Workshop, January 17-18, 2008, Silver Spring, Maryland. Meeting information
Adolescent Over-the-Counter (OTC) Drug Product Use: A Public Workshop, December 6 and 7, 2007 NIH Natcher Conference Center, Bethesda, Maryland. Meeting information
Public Meeting on Essential Uses of Ozone Depleting Substances, December 5, 2007, Rockville, Maryland. Meeting Information
International Conference on Harmonization (ICH) Public Meeting October 10, 2007, Rockville MD. Meeting information
Public Meeting on Essential Uses of Ozone Depleting Substances, Rockville, MD, August 2, 2007. Meeting information
Public Hearing on Use of Medication Guides to Distribute Drug Risk Information to Patients, June 12-13, 2007, Washington, D.C. Meeting Information
Implementation of Risk Minimization Action Plans (RiskMAPs) to Support Quality Use of Pharmaceuticals: Opportunities and Challenges, June 25-26, 2007, Rockville, MD. Meeting information
FDA’s Pharmaceutical Quality Initiatives – Implementation of a Modern
Risk-Based Approach, February 28 to March 2, 2007, Bethesda North
Marriott Hotel and Conference Center, Bethesda, Maryland. More Information
Public Meeting on Supplements and Other Changes to an Approved Application. February 7, 2007, Rockville, MD. Meeting information
Public Meeting on Improving Patient Safety by Enhancing the Container Labeling for Parenteral Infusion Drug Products, National Institutes of Health, Bethesda, MD, January 11, 2007. Meeting Information
Public workshop on issues related to the application process for seeking approval for marketed unapproved drugs, January 9, 2007. Federal Register notice [TXT] [PDF] Meeting Information
CDER Teleconference: “An Introduction to the Improved FDA Prescription Drug Labeling” Tuesday, November 7, 2006 12:30 p.m. – 2:00 p.m. Eastern time. Teleconference Information and Registration
Multiple Myloma Endpoints Meeting, October 26, 2006, Washington, DC. Meeting Information
CDER Forum for International Regulatory Authorities, September 25 - 28, 2006, Rockville, MD. Program Information and Registration
CDER Live! -
Understanding FDA's New Requirements for Prescription Drug Labeling,
May 9, 2006, 1 PM to 4 PM EDT.
Program Information and Registration.
Small Pharmaceutical Business Educational Forum Public
Workshop, April 25, 2006.
Meeting
Information
Ovarian Cancer Endpoints - FDA and the American Society of Clinical Oncology (ASCO), with
co-sponsorship by the American Association for Cancer Research (AACR), April 26, 2006,
7:30 to 5:00 pm, North Bethesda, Maryland.
Meeting Information
Industry Experts, Medical Specialists and Regulators Discuss
Monitoring and Evaluating Fetal Effects of Drug Exposure, May 1-3, 2006,
Washington, DC Meeting Information
Public Workshop on Emerging Clostridial Disease,
May 11, 2006,
Atlanta, Georgia.
Meeting Information
Public Workshop on Clinical Trial End Points in Primary Brain Tumors,
January 20, 2006, 8:00 a.m. to ~ 5:00 p.m. (TBD), North Bethesda, MD.
Meeting Information [PDF]
[Word]
Follow-on Biologics Workshop: Scientific Issues in Assessing the
Similarity of Follow-on Protein Products, New York City, NY, December
12-14, 2005.
Meeting
Information
2005 FDA cGMP China Training Program, December 5-7, Bejing, China.
Program Information
Public Hearing on CDER's Current Risk Communication Strategies for Human Drugs, December 7-8, 2005 Public Hearing
Information
Public Hearing on Direct-to-Consumer Promotion of Medical Products,
November 1 and 2, 2005, Washington, DC 20594.
Public Hearing Information.
Electronic Common Technical Document (eCTD) Tutorial,
Thursday, October 20, 2005, Rockville, MD.
Information and Registration
Overview of the ECG Warehouse and Review Process: Public Workshop,
September 30, 2005, Rockville, Maryland.
Workshop Information.
Public Meeting for
Levothyroxine Sodium Therapeutic Equivalence, May 23, 2005,
Washington, DC.
Small Business Drug Educational Forum Public Workshop, May 11,
2005. Meeting Information and
Registration
Electronic Common
Technical Document (eCTD) Workshop, Friday, April 22, 2005.
Workshop Agenda and Presentations
Public Hearing: Use of Color on Pharmaceutical Product Labels,
Labeling and Packaging.
March 7, 2005, NIH Campus,
Bethesda, MD. Notices of participation are due February 11, 2005.
Meeting Information [TXT]
[PDF];
Agenda and Presentations; Meeting
transcript [Word] or [PDF]
Follow-on Protein Pharmaceuticals,
February 14-16, 2005, Arlington, VA.
Meeting
Information
Scientific Considerations Related to Developing Follow-On Protein
Products
Date and Time: Meeting Information and Presentations
Evaluating Drug Names for Similarities: Methods and
Approaches, Public Meeting (name changed from "Minimizing Medication
Errors - Evaluating the Drug Naming Process"). June 26, 2003, The
Renaissance Washington DC Hotel. Meeting
Information;
Meeting
Agenda
Back
to Top 
CDER Calendar
 PDF requires the free
Adobe
Acrobat Reader
Last updated: April 30, 2009 |
|
